Search Results - "Tsunematsu, Satoshi"

Refine Results
  1. 1

    Synchronous Primary Lung Adenocarcinoma and Hepatocellular Carcinoma Successfully Treated with a Combination of Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel by Egawa, Takashi, Masuzawa, Keita, Nakayama, Sohei, Maeda, Ichiro, Tsunematsu, Satoshi, Suzuki, Yukio, Suzuki, Yusuke

    Published in Internal Medicine (15-10-2021)
    “…Chemotherapy for multiple primary malignancies is challenging. We herein report a case of synchronous primary lung adenocarcinoma and hepatocellular carcinoma…”
    Get full text
    Journal Article
  2. 2

    Campylobacter by Tsunematsu, Satoshi

    Published in Nihon rinshō (01-08-2012)
    “…Campylobacter bacterial infection is the second most cause of food poisoning in Japan. Patients are often found in outpatient clinic with symptom of severe…”
    Get more information
    Journal Article
  3. 3

    Natural toxin poisoning by Tsunematsu, Satoshi

    Published in Nihon rinshō (01-08-2012)
    “…Natural toxin poisoning often occurs when amateur who has no expert knowledge of food collects and cooks the wrong material. In many cases, the symptoms of…”
    Get more information
    Journal Article
  4. 4

    Pentoxifylline prevents pig serum-induced rat liver fibrosis by inhibiting interleukin-6 production by Toda, Kyoko, Kumagai, Naoki, Kaneko, Fumihiko, Tsunematsu, Satoshi, Tsuchimoto, Kanji, Saito, Hidetsugu, Hibi, Toshifumi

    Published in Journal of gastroenterology and hepatology (01-05-2009)
    “…Background/Aim:  Pig serum‐induced rat liver fibrosis is a model of liver fibrosis in the absence of obvious hepatocyte injury. Penoxifylline (PTX), a xanthine…”
    Get full text
    Journal Article
  5. 5

    Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis by Sugino, Haruko, Kumagai, Naoki, Watanabe, Sakiko, Toda, Kyoko, Takeuchi, Osamu, Tsunematsu, Satoshi, Morinaga, Shojiroh, Tsuchimoto, Kanji

    Published in Journal of gastroenterology and hepatology (01-12-2008)
    “…Background and Aim:  The effect of polaprezinc, a zinc‐carnosine chelate compound, on the development of non‐alcoholic steatohepatitis (NASH) was investigated…”
    Get full text
    Journal Article
  6. 6

    Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis by Kitamura, Kumi, Tada, Shinichiro, Nakamoto, Nobuhiro, Toda, Kyoko, Horikawa, Hitomi, Kurita, Satoshi, Tsunematsu, Satoshi, Kumagai, Naoki, Ishii, Hiromasa, Saito, Hidetsugu, Hibi, Toshifumi

    Published in Journal of gastroenterology and hepatology (01-11-2007)
    “…Background and Aim:  The molecular mechanisms underlying the involvement of the renin‐angiotensin system in hepatic fibrosis are unclear. Recently, it was…”
    Get full text
    Journal Article
  7. 7

    Pulmonary tuberculosis following anti-tumor necrosis factor-α therapy in Crohn's disease:a case report by Hara, Yusuke, Kobayashi, Taku, Okabayashi, Shinji, Nakano, Masaru, Sagami, Shintaro, Ozaki, Ryo, Nakayama, Sohei, Suzuki, Yusuke, Tsunematsu, Satoshi, Hibi, Toshifumi

    Published in Nippon Shōkakibyō Gakkai zasshi (2018)
    “…Anti-tumor necrosis factor-α (TNF-α) is a principal treatment for Crohn's disease (CD). However, it increases the susceptibility to tuberculosis (TB)…”
    Get more information
    Journal Article
  8. 8

    Clinical significance of human intestinal spirochetosis: a retrospective study by Umeda, Satoko, Serizawa, Hiroshi, Kobayashi, Taku, Toyonaga, Takahiko, Saito, Eiko, Nakano, Masaru, Higuchi, Hajime, Tsunematsu, Satoshi, Watanabe, Noriaki, Hibi, Toshifumi, Morinaga, Shojiro

    Published in Nippon Shōkakibyō Gakkai zasshi (2017)
    “…The clinical and pathological features of human intestinal spirochetosis (HIS) are not well known. Here we report 55 patients with HIS who were diagnosed at…”
    Get more information
    Journal Article
  9. 9

    Clinical usefulness of edaravone for acute liver injury by TADA, SHINICHIRO, NAKAMOTO, NOBUHIRO, KAMEYAMA, KAORI, TSUNEMATSU, SATOSHI, KUMAGAI, NAOKI, SAITO, HIDETSUGU, ISHII, HIROMASA

    Published in Journal of gastroenterology and hepatology (01-07-2003)
    “…Background: Edaravone, a newly synthesized radical scavenger, has shown an excellent effect on treating stroke patients. The effect of edaravone on carbon…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Helicobacter pylori prevalence in dentists in Japan: a seroepidemiological study by Matsuda, Reikei, Morizane, Toshio, Tsunematsu, Satoshi, Kawana, Ichiro, Tomiyama, Masakazu

    Published in Journal of gastroenterology (01-04-2002)
    “…The infection mode of Helicobacter pylori is not well known. In order to prove that frequent exposure to saliva and dental plaque does not constitute a risk…”
    Get full text
    Journal Article
  14. 14
  15. 15

    A case of pneumatosis cystoides intestinalis induced by steroid pulse therapy for severe acute hepatitis B by Ohara, Hiroshi, Kato, Yukako, Nakano, Masaru, Ishii, Yasuhisa, Serizawa, Hiroshi, Watanabe, Noriaki, Wakabayashi, Kanji, Tsunematsu, Satoshi, Kumagai, Naoki, Tsuchimoto, Kanji, Hibi, Toshifumi

    Published in Nippon Shōkakibyō Gakkai zasshi (01-07-2011)
    “…A 26-year-old Japanese woman was admitted to the hospital because of fever and general fatigue. A diagnosis of acute hepatitis B was given because of high…”
    Get more information
    Journal Article
  16. 16

    Synchronous Primary Lung Adenocarcinoma and Hepatocellular Carcinoma Successfully Treated with a Combination of Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel by Egawa, Takashi, Masuzawa, Keita, Nakayama, Sohei, Maeda, Ichiro, Tsunematsu, Satoshi, Suzuki, Yukio, Suzuki, Yusuke

    Published in Internal Medicine (2021)
    “…Chemotherapy for multiple primary malignancies is challenging. We herein report a case of synchronous primary lung adenocarcinoma and hepatocellular carcinoma…”
    Get full text
    Journal Article
  17. 17

    Safety and efficacy of faldaprevir with pegylated interferon alfa-2a and ribavirin in Japanese patients with chronic genotype-1 hepatitis C infection by Nishiguchi, Shuhei, Sakai, Yoshiyuki, Kuboki, Makoto, Tsunematsu, Satoshi, Urano, Yasuhisa, Sakamoto, Wataru, Tsuda, Yasuhiro, Steinmann, Gerhard, Omata, Masao

    Published in Liver international (01-01-2014)
    “…Background & Aims Faldaprevir (BI 201335) is a potent once‐daily (QD) NS3/4A protease inhibitor for the treatment of patients with genotype‐1 (GT‐1) hepatitis…”
    Get full text
    Journal Article
  18. 18

    Hepatic tumors induced by carbon tetrachloride in transgenic mice carrying a human c-H-ras proto-oncogene without mutations by Tsunematsu, S, Saito, H, Kagawa, T, Morizane, T, Hata, J, Nakamura, T, Ishii, H, Tsuchiya, M, Nomura, T, Katsuki, M

    Published in International journal of cancer (15-11-1994)
    “…Hepatic tumors were generated in mice by repeated administration of carbon tetrachloride (CCl4). Eight transgenic (Tg) mice carrying a human c-H-ras…”
    Get more information
    Journal Article
  19. 19

    Changes of antigen expression on human hepatoma cell lines caused by sodium butyrate, a differentiation inducer by Saito, H, Tada, S, Ebinuma, H, Tsunematsu, S, Kagawa, T, Kumagai, N, Inagaki, Y, Watanabe, T, Tsuchimoto, K, Morizane, T

    Published in Journal of gastroenterology (01-12-1994)
    “…We have previously reported the effect of a differentiation inducer, sodium butyrate (SB), on human hepatocellular carcinoma (HCC) cell lines, demonstrating…”
    Get full text
    Journal Article
  20. 20